[go: up one dir, main page]

RU95116687A - METHOD FOR TREATING PERINATAL DEFRACTION OF THE CENTRAL NERVOUS SYSTEM IN NEWBORNS - Google Patents

METHOD FOR TREATING PERINATAL DEFRACTION OF THE CENTRAL NERVOUS SYSTEM IN NEWBORNS

Info

Publication number
RU95116687A
RU95116687A RU95116687/14A RU95116687A RU95116687A RU 95116687 A RU95116687 A RU 95116687A RU 95116687/14 A RU95116687/14 A RU 95116687/14A RU 95116687 A RU95116687 A RU 95116687A RU 95116687 A RU95116687 A RU 95116687A
Authority
RU
Russia
Prior art keywords
newborns
nervous system
central nervous
defraction
treating perinatal
Prior art date
Application number
RU95116687/14A
Other languages
Russian (ru)
Other versions
RU2089189C1 (en
Inventor
Т.Н. Погорелова
А.А. Афонин
И.И. Крукиер
С.Е. Авилов
Н.Н. Лагодина
С.В. Малышева
Original Assignee
Ростовский научно-исследовательский институт акушерства и педиатрии
Filing date
Publication date
Application filed by Ростовский научно-исследовательский институт акушерства и педиатрии filed Critical Ростовский научно-исследовательский институт акушерства и педиатрии
Priority to RU95116687A priority Critical patent/RU2089189C1/en
Priority claimed from RU95116687A external-priority patent/RU2089189C1/en
Application granted granted Critical
Publication of RU2089189C1 publication Critical patent/RU2089189C1/en
Publication of RU95116687A publication Critical patent/RU95116687A/en

Links

Claims (1)

Способ лечения перинатального поражения центральной нервной системы у новорожденных, включающий применения альфа-токоферола, отличающийся тем, что 2%-ный альфа-токоферол в 50%-ном растворе димексида вводят путем электрофореза в течение 6 - 7 дней, затем определяют хемилюминесценцию крови и при величине светосуммы хемилюминесценции 5,7 квант/мин х 106 и ниже электрофорез отменяют.A method of treating perinatal damage to the central nervous system in newborns, including the use of alpha-tocopherol, characterized in that 2% alpha-tocopherol in a 50% solution of dimexide is administered by electrophoresis for 6 to 7 days, then blood chemiluminescence is determined and the magnitude of the chemiluminescence light sum of 5.7 quantum / min x 10 6 and lower electrophoresis is canceled.
RU95116687A 1995-09-27 1995-09-27 Method of treatment of perinatal central nervous system damage in newborns RU2089189C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95116687A RU2089189C1 (en) 1995-09-27 1995-09-27 Method of treatment of perinatal central nervous system damage in newborns

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95116687A RU2089189C1 (en) 1995-09-27 1995-09-27 Method of treatment of perinatal central nervous system damage in newborns

Publications (2)

Publication Number Publication Date
RU2089189C1 RU2089189C1 (en) 1997-09-10
RU95116687A true RU95116687A (en) 1998-01-10

Family

ID=20172437

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95116687A RU2089189C1 (en) 1995-09-27 1995-09-27 Method of treatment of perinatal central nervous system damage in newborns

Country Status (1)

Country Link
RU (1) RU2089189C1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2176911C2 (en) * 1999-07-27 2001-12-20 Нижегородский государственный научно-исследовательский институт травматологии и ортопедии Surgical method for treating burn wounds
RU2201226C3 (en) * 2001-07-10 2019-08-01 Общество С Ограниченной Ответственностью "Консорциум-Пик" ANTIEPILEPTIC MEANS WITH NOOTROPIC ACTION
RU2194518C1 (en) * 2001-07-30 2002-12-20 Государственный НИИ курортологии Method for treating early-aged children in case of perinatal encephalopathy
RU2237898C2 (en) * 2002-08-16 2004-10-10 ГУ "Ивановский научно-исследовательский институт материнства и детства им. В.Н. Городкова" Method for evaluating treatment effectiveness in the cases of newborns suffering from perinatal lesions of the central nervous system
RU2339043C1 (en) * 2007-09-18 2008-11-20 Государственное образовательное учреждение высшего профессионального образования Смоленская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию Method of diagnostics of consequences of perinayal lesions of central nervous system of small degree at children
RU2387369C1 (en) * 2008-10-23 2010-04-27 Федеральное Государственное Учреждение Ростовский НИИ акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Method of treating perinatal affection of central nervous system in newborns in critical state

Similar Documents

Publication Publication Date Title
ATE86247T1 (en) 3-INDOLPYRUVIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS.
DE69523350D1 (en) Treatment of hyperproliferative vascular diseases
ES2149971T3 (en) 5-SUBSTITUTED DERIVATIVES OF MYCOPHENOLIC ACID.
FI935306L (en) Use of purified, surface-modifying agents to prevent particle aggregation during sterilization
EP0706373A4 (en) TAXOL ENCAPSULATED IN LIPOSOMES AND METHOD OF USING SAME
FR2629714B1 (en) TRANSPARENT SHAMPOO COMPOSITION, MANUFACTURING METHOD THEREOF, AND METHOD OF USING SAME FOR HAIR TREATMENT
FI945912L (en) Proteinoid carriers and methods for their preparation and use
RU93047799A (en) COMPOSITIONS CONTAINING RETAIC ACIDS AND TOKOFEROL
DE4497012T1 (en) Improvements in the catalytic treatment of engine exhaust
BR9205609A (en) Orthomolecular process of treatment of sickle cell disease
DE69617729D1 (en) USE OF ANTIMINERALCORTICOID COMPOUNDS AGAINST THE DRUG DEACTIVATION SYNDROME
DE69130497D1 (en) New use of 1-alpha-hydroxylated-19-nor-vitamin-D compounds for the treatment of psoriasis
RU95116687A (en) METHOD FOR TREATING PERINATAL DEFRACTION OF THE CENTRAL NERVOUS SYSTEM IN NEWBORNS
ATE63815T1 (en) USE OF TIN PROTOPORPHYRIN AND TIN MESOPORPHYRIN IN THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF PSORIASIS.
ATE119770T1 (en) USE OF ACETYL L-CARNITINE FOR THE THERAPEUTIC TREATMENT OF COMA.
RU93038964A (en) METHOD FOR MODIFICATION OF IMMUNE SYSTEM-2
ATE185696T1 (en) OPHTALMIC COMPOSITIONS CONTAINING EMEDASTINE AND THEIR USE FOR THE TREATMENT OF ALLERGIC CONJUNCTIVITIS
ATE59778T1 (en) USE OF SULFONAMIDE DERIVATIVES IN THE MANUFACTURE OF AN ANTIVIRUS AGENT.
DE69434424D1 (en) IN VITRO CULTURAL PROCESS FOR DIFFERENT STADIAS OF TISSUE PARASITES
ATE174383T1 (en) USE OF TRI-N-BUTYL PHOSPHATE AT LOW PH IN SOLUTIONS OF BIOLOGICALLY ACTIVE PROTEINS FOR ENHANCED VIRUCIIDAL EFFECT
FR2684552B1 (en) USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS.
EA199900363A1 (en) NEW DERIVATIVES OF PENTA AERITRITIS, THEIR RECEIVING AND APPLICATION, AND ALSO INTERMEDIATE PRODUCTS FOR THEIR SYNTHESIS
DE3888727D1 (en) Use of ethylamine derivatives as antihypertensive agents.
RU93003584A (en) METHOD FOR TREATING SYNDROME OF POLYCYSTIC OVARY
ES2102019T3 (en) 2,3,4,5-TETRAHIDRO-1H-3-BENZAZEPINAS AND ITS PHARMACEUTICALLY ACCEPTABLE ADDITIONAL SALTS.